Iratumumab

From Self-sufficiency
Jump to: navigation, search
Iratumumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target CD30
Identifiers
CAS Number 640735-09-7
ATC code none
Chemical data
Formula C6358H9830N1682O1992S38
Molar mass 170 kDa[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease.[1]

This drug was developed by Medarex, Inc.

References

  1. Statement On A Nonproprietary Name Adopted By The USAN Council – Iratumumab, American Medical Association.